IDEAS home Printed from https://ideas.repec.org/f/pgu361.html
   My authors  Follow this author

G Emmanuel Guindon

Personal Details

First Name:G Emmanuel
Middle Name:
Last Name:Guindon
Suffix:
RePEc Short-ID:pgu361

Affiliation

Centre for Health Economics and Policy Analysis (CHEPA)
McMaster University

Hamilton, Canada
http://www.chepa.org/
RePEc:edi:chepaca (more details at EDIRC)

Research output

as
Jump to: Working papers Articles

Working papers

  1. G. Emmanuel Guindon & Arindam Nandi & Frank J. Chaloupka, IV & Prabhat Jha, 2011. "Socioeconomic Differences in the Impact of Smoking Tobacco and Alcohol Prices on Smoking in India," NBER Working Papers 17580, National Bureau of Economic Research, Inc.
  2. Jeremiah Hurley & Emmanuel Guindon, 2008. "Private Health Insurance in Canada," Centre for Health Economics and Policy Analysis Working Paper Series 2008-04, Centre for Health Economics and Policy Analysis (CHEPA), McMaster University, Hamilton, Canada.
  3. G. Emmanuel Guindon & Kathy Georgiades & Michael H. Boyle, 2007. "Susceptibility to Smoking among Non-smoking East-Asian Youth: A Multilevel Analysis," Centre for Health Economics and Policy Analysis Working Paper Series 2007-08, Centre for Health Economics and Policy Analysis (CHEPA), McMaster University, Hamilton, Canada.
  4. Jeremiah Hurley & G. Emmanuel Guindon & Vicky Rynard & Steve Morgan, 2007. "Publicly Funded Medical Savings Accounts: Expenditures and Distributional Impacts," Centre for Health Economics and Policy Analysis Working Paper Series 2007-01, Centre for Health Economics and Policy Analysis (CHEPA), McMaster University, Hamilton, Canada.
  5. Guindon, G. Emmanuel & Perucic, Anne-Marie & Boisclair, David, 2004. "Higher Tobacco Prices and Taxes in South East Asia: An Effective Tool to Reduce Tobacco Use, Save Lives and Generate Revenue," University of California at San Francisco, Center for Tobacco Control Research and Education qt1t41d7kz, Center for Tobacco Control Research and Education, UC San Francisco.
  6. Guindon, G. Emmanuel & Boisclair, David, 2003. "Past, Current and Future Trends in Tobacco Use," University of California at San Francisco, Center for Tobacco Control Research and Education qt4q57d5vp, Center for Tobacco Control Research and Education, UC San Francisco.

Articles

  1. Guo, Elaine Xiaoyu & Sweetman, Arthur & Guindon, G. Emmanuel, 2020. "Socioeconomic differences in prescription drug supplemental coverage in Canada: A repeated cross-sectional study," Health Policy, Elsevier, vol. 124(3), pages 252-260.
  2. G. Emmanuel Guindon & Guillermo R. Paraje & Ricardo Chávez, 2018. "Prices, Inflation, And Smoking Onset: The Case Of Argentina," Economic Inquiry, Western Economic Association International, vol. 56(1), pages 424-445, January.
  3. Guindon, G.E. & Paraje, G.R. & Chaloupka, F.J., 2015. "The impact of prices and taxes on the use of tobacco products in latin america and the caribbean," American Journal of Public Health, American Public Health Association, vol. 105(3), pages 9-19.
  4. G. Guindon, 2014. "The impact of tobacco prices on smoking onset in Vietnam: duration analyses of retrospective data," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 15(1), pages 19-39, January.
  5. Guindon, G. Emmanuel, 2014. "The impact of health insurance on health services utilization and health outcomes in Vietnam," Health Economics, Policy and Law, Cambridge University Press, vol. 9(4), pages 359-382, October.
  6. G. Emmanuel Guindon & Paul Contoyannis, 2012. "A Second Look At Pharmaceutical Spending As Determinants Of Health Outcomes In Canada," Health Economics, John Wiley & Sons, Ltd., vol. 21(12), pages 1477-1495, December.
  7. G Emmanuel Guindon & Paul Contoyannis, 2012. "A Response To Crémieux, Meilleur, Ouellette And Petit," Health Economics, John Wiley & Sons, Ltd., vol. 21(12), pages 1499-1501, December.
  8. Jeremiah Hurley & G. Emmanuel Guindon & Vicki Rynard & Steve Morgan, 2008. "Publicly funded medical savings accounts: expenditure and distributional impacts in Ontario, Canada," Health Economics, John Wiley & Sons, Ltd., vol. 17(10), pages 1129-1151, October.

Citations

Many of the citations below have been collected in an experimental project, CitEc, where a more detailed citation analysis can be found. These are citations from works listed in RePEc that could be analyzed mechanically. So far, only a minority of all works could be analyzed. See under "Corrections" how you can help improve the citation analysis.

Wikipedia or ReplicationWiki mentions

(Only mentions on Wikipedia that link back to a page on a RePEc service)
  1. G. Emmanuel Guindon & Paul Contoyannis, 2012. "A Second Look At Pharmaceutical Spending As Determinants Of Health Outcomes In Canada," Health Economics, John Wiley & Sons, Ltd., vol. 21(12), pages 1477-1495, December.

    Mentioned in:

    1. A Second Look At Pharmaceutical Spending As Determinants Of Health Outcomes In Canada (Health Economics 2012) in ReplicationWiki ()

Working papers

  1. G. Emmanuel Guindon & Arindam Nandi & Frank J. Chaloupka, IV & Prabhat Jha, 2011. "Socioeconomic Differences in the Impact of Smoking Tobacco and Alcohol Prices on Smoking in India," NBER Working Papers 17580, National Bureau of Economic Research, Inc.

    Cited by:

    1. Violeta Chacon & Guillermo Paraje & Joaquin Barnoya & Frank J Chaloupka, 2018. "Own-price, cross-price, and expenditure elasticities on sugar-sweetened beverages in Guatemala," PLOS ONE, Public Library of Science, vol. 13(10), pages 1-12, October.
    2. G. Guindon, 2014. "The impact of tobacco prices on smoking onset in Vietnam: duration analyses of retrospective data," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 15(1), pages 19-39, January.
    3. Subramanian, Arjunan & Kumar, Parmod, 2017. "The impact of price policy on demand for alcohol in rural India," Social Science & Medicine, Elsevier, vol. 191(C), pages 176-185.
    4. Justin S. White & Hana Ross, 2015. "Smokers' Strategic Responses to Sin Taxes: Evidence from Panel Data in Thailand," Health Economics, John Wiley & Sons, Ltd., vol. 24(2), pages 127-141, February.
    5. Crespi, Francesco & Liberati, Paolo & Paradiso, Massimo & Scialà, Antonio & Tedeschi, Simone, 2021. "Smokers are different: The impact of price increases on smoking reduction and downtrading," Economic Modelling, Elsevier, vol. 97(C), pages 326-334.
    6. Guillermo Paraje, 2016. "The Effect of Price and Socio-Economic Level on the Consumption of Sugar-Sweetened Beverages (SSB): The Case of Ecuador," PLOS ONE, Public Library of Science, vol. 11(3), pages 1-13, March.

  2. Jeremiah Hurley & Emmanuel Guindon, 2008. "Private Health Insurance in Canada," Centre for Health Economics and Policy Analysis Working Paper Series 2008-04, Centre for Health Economics and Policy Analysis (CHEPA), McMaster University, Hamilton, Canada.

    Cited by:

    1. Laetitia Lebihan, 2023. "The impact of a mandatory universal drug insurance program on health behaviors and outcomes," Post-Print hal-04288368, HAL.
    2. J.C. Herbert Emery, 2016. "Tax-Assisted Approaches For Helping Canadians Meet Out-of-Pocket Health-Care Costs," SPP Research Papers, The School of Public Policy, University of Calgary, vol. 9(23), June.
    3. Grignon, M. & Longo, C.J. & Marchildon, G.P. & Officer, S., 2020. "The 2018 decision to establish an Advisory Council on adding pharmaceuticals to universal health coverage in Canada," Health Policy, Elsevier, vol. 124(1), pages 7-11.
    4. Katya Kartashova & Ben Tomlin, 2013. "House Prices, Consumption and the Role of Non-Mortgage Debt," Staff Working Papers 13-2, Bank of Canada.
    5. Wang, Chao & Li, Qing & Sweetman, Arthur & Hurley, Jeremiah, 2015. "Mandatory universal drug plan, access to health care and health: Evidence from Canada," Journal of Health Economics, Elsevier, vol. 44(C), pages 80-96.
    6. Charbonneau, Mathieu & Gagnon, Marc-André, 2018. "Surviving niche busters: Main strategies employed by Canadian private insurers facing the arrival of high cost specialty drugs," Health Policy, Elsevier, vol. 122(12), pages 1295-1301.
    7. Sara Allin & Jeremiah Hurley, 2009. "Inequity in publicly funded physician care: what is the role of private prescription drug insurance?," Health Economics, John Wiley & Sons, Ltd., vol. 18(10), pages 1218-1232, October.
    8. Chao Wang, 2012. "Mandatory Universal Drug Plan, Access to Health Care and Health: Evidence from Quebec, Canada," Department of Economics Working Papers 2012-14, McMaster University.

  3. Jeremiah Hurley & G. Emmanuel Guindon & Vicky Rynard & Steve Morgan, 2007. "Publicly Funded Medical Savings Accounts: Expenditures and Distributional Impacts," Centre for Health Economics and Policy Analysis Working Paper Series 2007-01, Centre for Health Economics and Policy Analysis (CHEPA), McMaster University, Hamilton, Canada.

    Cited by:

    1. Wouters, Olivier J. & Cylus, Jonathan & Yang, Wei & Thomson, Sarah & McKee, Martin, 2016. "Medical savings accounts: assessing their impact on efficiency, equity, and financial protection in health care," LSE Research Online Documents on Economics 65448, London School of Economics and Political Science, LSE Library.

  4. Guindon, G. Emmanuel & Perucic, Anne-Marie & Boisclair, David, 2004. "Higher Tobacco Prices and Taxes in South East Asia: An Effective Tool to Reduce Tobacco Use, Save Lives and Generate Revenue," University of California at San Francisco, Center for Tobacco Control Research and Education qt1t41d7kz, Center for Tobacco Control Research and Education, UC San Francisco.

    Cited by:

    1. G. Emmanuel Guindon & Arindam Nandi & Frank J. Chaloupka, IV & Prabhat Jha, 2011. "Socioeconomic Differences in the Impact of Smoking Tobacco and Alcohol Prices on Smoking in India," NBER Working Papers 17580, National Bureau of Economic Research, Inc.

  5. Guindon, G. Emmanuel & Boisclair, David, 2003. "Past, Current and Future Trends in Tobacco Use," University of California at San Francisco, Center for Tobacco Control Research and Education qt4q57d5vp, Center for Tobacco Control Research and Education, UC San Francisco.

    Cited by:

    1. Rodríguez-Planas, Núria & Sanz-de-Galdeano, Anna, 2019. "Intergenerational transmission of gender social norms and teenage smoking," Social Science & Medicine, Elsevier, vol. 222(C), pages 122-132.
    2. Azmat Gani, 2009. "Some Aspects of Communicable and Non-communicable Diseases in Pacific Island Countries," Social Indicators Research: An International and Interdisciplinary Journal for Quality-of-Life Measurement, Springer, vol. 91(2), pages 171-187, April.
    3. Wolff, Hendrik & Chong, Howard & Auffhammer, Maximilian, 2008. "Consequences of Data Error in Aggregate Indicators: Evidence from the Human Development Index," CUDARE Working Papers 6502, University of California, Berkeley, Department of Agricultural and Resource Economics.
    4. Anh Ngo & Geoffrey T. Fong & Lorraine V. Craig & Ce Shang, 2019. "Analysis of Gender Differences in the Impact of Taxation and Taxation Structure on Cigarette Consumption in 17 ITC Countries," IJERPH, MDPI, vol. 16(7), pages 1-11, April.
    5. Wipfli, Heather & Huang, Grace, 2011. "Power of the process: Evaluating the impact of the Framework Convention on Tobacco Control negotiations," Health Policy, Elsevier, vol. 100(2), pages 107-115.
    6. Pampel, Fred, 2008. "Tobacco use in sub-Sahara Africa: Estimates from the demographic health surveys," Social Science & Medicine, Elsevier, vol. 66(8), pages 1772-1783, April.
    7. Sanath Sameera Wijesinghe, 2019. "Tobacco Epidemic and Development: The South Asian Experience," Annals of Social Sciences & Management studies, Juniper Publishers Inc., vol. 4(3), pages 59-68, September.
    8. Wolff, Hendrik & Chong, Howard & Auffhammer, Maximilian, 2008. "Consequences of Data Error in Aggregate Indicators: Evidence from the Human Development Index," IZA Discussion Papers 3346, Institute of Labor Economics (IZA).
    9. Ajay Mahal & Lainie Sutton, 2014. "Economic prosperity and non-communicable disease: understanding the linkages," Chapters, in: Raghbendra Jha & Raghav Gaiha & Anil B. Deolalikar (ed.), Handbook on Food, chapter 12, pages 278-324, Edward Elgar Publishing.
    10. Xianglong Xu & Lingli Liu & Manoj Sharma & Yong Zhao, 2015. "Smoking-Related Knowledge, Attitudes, Behaviors, Smoking Cessation Idea and Education Level among Young Adult Male Smokers in Chongqing, China," IJERPH, MDPI, vol. 12(2), pages 1-15, February.
    11. Rodríguez-Planas, Núria & Sanz-de-Galdeano, Anna, 2016. "Social Norms and Teenage Smoking: The Dark Side of Gender Equality," IZA Discussion Papers 10134, Institute of Labor Economics (IZA).
    12. Ansari-Moghaddam, Alireza & Rakhshani, Fatemeh & Shahraki-Sanavi, Fariba & Mohammadi, Mahdi & Miri-Bonjar, Mahmodreza & Bakhshani, Nour-Mohammad, 2016. "Prevalence and patterns of tobacco, alcohol, and drug use among Iranian adolescents: A meta-analysis of 58 studies," Children and Youth Services Review, Elsevier, vol. 60(C), pages 68-79.
    13. Wolff, Hendrik & Chong, Howard & Auffhammer, Maximilian, 2009. "Human Development Index: Are Developing Countries Misclassified? (former title: "Consequences of Data Error in Aggregate Indicators: Evidence from the Human Development Index)," 2009 Annual Meeting, July 26-28, 2009, Milwaukee, Wisconsin 49763, Agricultural and Applied Economics Association.

Articles

  1. Guo, Elaine Xiaoyu & Sweetman, Arthur & Guindon, G. Emmanuel, 2020. "Socioeconomic differences in prescription drug supplemental coverage in Canada: A repeated cross-sectional study," Health Policy, Elsevier, vol. 124(3), pages 252-260.

    Cited by:

    1. Laetitia Lebihan, 2023. "The impact of a mandatory universal drug insurance program on health behaviors and outcomes," Post-Print hal-04288368, HAL.
    2. Ahmad, Afreen & Abbas, Momina & Miregwa, Benard & Holbrook, Anne Marie, 2022. "Variability in prescription medication coverage for children and youth across Canada: A scoping review," Health Policy, Elsevier, vol. 126(3), pages 269-279.
    3. Antonipillai, Valentina & Guindon, G. Emmanuel & Sweetman, Arthur & Baumann, Andrea & Wahoush, Olive & Schwartz, Lisa, 2021. "Associations of health services utilization by prescription drug coverage and immigration category in Ontario, Canada," Health Policy, Elsevier, vol. 125(10), pages 1311-1321.

  2. G. Emmanuel Guindon & Guillermo R. Paraje & Ricardo Chávez, 2018. "Prices, Inflation, And Smoking Onset: The Case Of Argentina," Economic Inquiry, Western Economic Association International, vol. 56(1), pages 424-445, January.

    Cited by:

    1. Samuel Asare & Michal Stoklosa & Jeffrey Drope & Aidan Larsen, 2019. "Effects of Prices on Youth Cigarette Smoking and Tobacco Use Initiation in Ghana and Nigeria," IJERPH, MDPI, vol. 16(17), pages 1-14, August.
    2. Michael A. Catalano & Donna B. Gilleskie, 2021. "Impacts of local public smoking bans on smoking behaviors and tobacco smoke exposure," Health Economics, John Wiley & Sons, Ltd., vol. 30(8), pages 1719-1744, August.
    3. Mustapha Immurana & Micheal Kofi Boachie & Maxwell Ayindenaba Dalaba & Kofi Mintah Oware & Toby Joseph Mathew K.K. & Martin Amogre Ayanore & Hadrat Mohammed Yusif, 2021. "An empirical analysis of the effect of tobacco taxation on economic growth in 38 African countries," Journal of International Development, John Wiley & Sons, Ltd., vol. 33(8), pages 1257-1269, November.

  3. Guindon, G.E. & Paraje, G.R. & Chaloupka, F.J., 2015. "The impact of prices and taxes on the use of tobacco products in latin america and the caribbean," American Journal of Public Health, American Public Health Association, vol. 105(3), pages 9-19.

    Cited by:

    1. Miguel à ngel Mendoza-González & Alberto Villagra-Piña, 2021. "Efectos de la Covid-19 y la restricción a la movilidad de las personas sobre el consumo adictivo de cigarros en México, 2005-2020," Remef - Revista Mexicana de Economía y Finanzas Nueva Época REMEF (The Mexican Journal of Economics and Finance), Instituto Mexicano de Ejecutivos de Finanzas, IMEF, vol. 16(3), pages 1-20, Julio - S.
    2. Enver Tahiraj & Mladen Cubela & Ljerka Ostojic & Jelena Rodek & Natasa Zenic & Damir Sekulic & Blaz Lesnik, 2016. "Prevalence and Factors Associated with Substance Use and Misuse among Kosovar Adolescents; Cross Sectional Study of Scholastic, Familial-, and Sports-Related Factors of Influence," IJERPH, MDPI, vol. 13(5), pages 1-13, May.
    3. Burguillo, Mercedes & Romero-Jordán, Desiderio & Sanz-Sanz, José-Félix, 2019. "Efficacy of the tobacco tax policy in the presence of product heterogeneity: A pseudo-panel approach applied to Spain," Health Policy, Elsevier, vol. 123(10), pages 924-931.
    4. Mannocci, Alice & Backhaus, Insa & D’Egidio, Valeria & Federici, Antonio & Villari, Paolo & La Torre, Giuseppe, 2019. "What public health strategies work to reduce the tobacco demand among young people? An umbrella review of systematic reviews and meta-analyses," Health Policy, Elsevier, vol. 123(5), pages 480-491.
    5. Ahmed Mohammed Alqarni, 2020. "Saudi Smokers' Behaviors After a 100% Tax Increase," International Journal of Marketing Studies, Canadian Center of Science and Education, vol. 11(1), pages 150-150, March.
    6. Michael Chaiton & Jolene Dubray & G. Emmanuel Guindon & Robert Schwartz, 2021. "Tobacco Endgame Simulation Modelling: Assessing the Impact of Policy Changes on Smoking Prevalence in 2035," Forecasting, MDPI, vol. 3(2), pages 1-9, April.
    7. Hernandez-Vasquez, Akram, 2016. "Burden of smoking-related disease and potential impact of cigarette price increase in Peru," MPRA Paper 75677, University Library of Munich, Germany.
    8. G. Emmanuel Guindon & Guillermo R. Paraje & Ricardo Chávez, 2018. "Prices, Inflation, And Smoking Onset: The Case Of Argentina," Economic Inquiry, Western Economic Association International, vol. 56(1), pages 424-445, January.
    9. Ariel Bardach & Andrea Alcaraz & Javier Roberti & Agustín Ciapponi & Federico Augustovski & Andrés Pichon-Riviere, 2021. "Optimizing Tobacco Advertising Bans in Seven Latin American Countries: Microsimulation Modeling of Health and Financial Impact to Inform Evidence-Based Policy," IJERPH, MDPI, vol. 18(10), pages 1-13, May.

  4. G. Guindon, 2014. "The impact of tobacco prices on smoking onset in Vietnam: duration analyses of retrospective data," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 15(1), pages 19-39, January.

    Cited by:

    1. Samuel Asare & Michal Stoklosa & Jeffrey Drope & Aidan Larsen, 2019. "Effects of Prices on Youth Cigarette Smoking and Tobacco Use Initiation in Ghana and Nigeria," IJERPH, MDPI, vol. 16(17), pages 1-14, August.
    2. Martin Gonzalez-Rozada & Giselle Montamat, 2015. "How increasing tobacco prices affects the decision to start and quit smoking: evidence from Argentina," Department of Economics Working Papers wp201501, Universidad Torcuato Di Tella.
    3. Vellios, Nicole & van Walbeek, Corne, 2014. "Determinants of smoking initiation in South Africa," SALDRU Working Papers 128, Southern Africa Labour and Development Research Unit, University of Cape Town.
    4. cuong, nguyen, 2010. "Smoking behavior in Vietnam: demographic and socioeconomic determinants," MPRA Paper 36516, University Library of Munich, Germany.
    5. Martin Gonzalez-Rozada & Giselle Montamat, 2019. "How Raising Tobacco Prices Affects the Decision to Start and Quit Smoking: Evidence from Argentina," IJERPH, MDPI, vol. 16(19), pages 1-11, September.
    6. G. Emmanuel Guindon & Guillermo R. Paraje & Ricardo Chávez, 2018. "Prices, Inflation, And Smoking Onset: The Case Of Argentina," Economic Inquiry, Western Economic Association International, vol. 56(1), pages 424-445, January.
    7. Mohamed Arouri & Adel Ben-Youssef & Cuong Nguyen Viet, 2017. "Does having more children increase the likelihood of parental smoking? Evidence from Vietnam," Oxford Development Studies, Taylor & Francis Journals, vol. 45(3), pages 260-275, July.
    8. Ali Palali & Jan C. Ours, 2019. "The impact of tobacco control policies on smoking initiation in eleven European countries," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 20(9), pages 1287-1301, December.
    9. Cuong Viet Nguyen, 2012. "Demographic and Socio-economic Determinants of Smoking Behavior: Evidence from Vietnam," Economics Bulletin, AccessEcon, vol. 32(3), pages 2300-2312.
    10. Martin Gonzalez-Rozada & Giselle Montamat, 2015. "How increasing tobacco prices affects the decision to start and quit smoking: evidence from Argentina," Department of Economics Working Papers 2015_3, Universidad Torcuato Di Tella.

  5. Guindon, G. Emmanuel, 2014. "The impact of health insurance on health services utilization and health outcomes in Vietnam," Health Economics, Policy and Law, Cambridge University Press, vol. 9(4), pages 359-382, October.

    Cited by:

    1. Sophie Mitra & Michael Palmer & Shannon Pullaro & Daniel Mont & Nora Groce, 2017. "Health Insurance and Children in Low- and Middle-income Countries: A Review," The Economic Record, The Economic Society of Australia, vol. 93(302), pages 484-500, September.
    2. Darius Erlangga & Marc Suhrcke & Shehzad Ali & Karen Bloor, 2019. "The impact of public health insurance on health care utilisation, financial protection and health status in low- and middle-income countries: A systematic review," PLOS ONE, Public Library of Science, vol. 14(8), pages 1-20, August.
    3. Le, Nga T.Q. & Groot, Wim & Tomini, Sonila & Tomini, Florian, 2017. "Effects of health insurance on labour supply: Evidence from the health care fund for the poor in Viet Nam," MERIT Working Papers 2017-050, United Nations University - Maastricht Economic and Social Research Institute on Innovation and Technology (MERIT).
    4. Midori Matsushima & Hiroyuki Yamada & Yasuharu Shimamura, 2020. "Analysis on demand‐ and supply‐side responses during the expansion of health insurance coverage in Vietnam: Challenges and policy implications toward universal health coverage," Review of Development Economics, Wiley Blackwell, vol. 24(1), pages 144-166, February.
    5. Le, Nga & Groot, Wim & Tomini, Sonila & Tomini, Florian, 2018. "Health insurance and patient satisfaction: Evidence from the poorest regions of Vietnam," MERIT Working Papers 2018-040, United Nations University - Maastricht Economic and Social Research Institute on Innovation and Technology (MERIT).
    6. Sha Chen & Zhiye Lin & Xiaoru Fan & Jushuang Li & Yao-Jie Xie & Chun Hao, 2022. "The Comparison of Various Types of Health Insurance in the Healthcare Utilization, Costs and Catastrophic Health Expenditures among Middle-Aged and Older Chinese Adults," IJERPH, MDPI, vol. 19(10), pages 1-14, May.
    7. Chaw-Yin Myint & Milena Pavlova & Khin-Ni-Ni Thein & Wim Groot, 2019. "A systematic review of the health-financing mechanisms in the Association of Southeast Asian Nations countries and the People’s Republic of China: Lessons for the move towards universal health coverag," PLOS ONE, Public Library of Science, vol. 14(6), pages 1-18, June.

  6. G. Emmanuel Guindon & Paul Contoyannis, 2012. "A Second Look At Pharmaceutical Spending As Determinants Of Health Outcomes In Canada," Health Economics, John Wiley & Sons, Ltd., vol. 21(12), pages 1477-1495, December.

    Cited by:

    1. Matthew Calver, 2016. "Measuring the Appropriate Outcomes for Better Decision-Making: A Framework to Guide the Analysis of Health Policy," CSLS Research Reports 2016-03, Centre for the Study of Living Standards.
    2. Hope Corman & Dhaval M. Dave & Nancy E. Reichman, 2017. "Evolution of the Infant Health Production Function," Working Papers id:12331, eSocialSciences.
    3. Gallet, Craig A. & Doucouliagos, Hristos, 2017. "The impact of healthcare spending on health outcomes: A meta-regression analysis," Social Science & Medicine, Elsevier, vol. 179(C), pages 9-17.
    4. Felipa de Mello-Sampayo & Sofia de Sousa Vale, 2012. "Financing Health Care Expenditure in the OECD Countries: Evidence from a Heterogeneous, Cross-Sectionally Dependent Panel," Working Papers Department of Economics 2012/34, ISEG - Lisbon School of Economics and Management, Department of Economics, Universidade de Lisboa.
    5. Pierre‐Yves CrÉmieux & Marie‐Claude Meilleur & Pierre Ouellette & Patrick Petit, 2012. "A Reply To ‘A Second Look At Pharmaceutical Spending As Determinants Of Health Outcomes In Canada’," Health Economics, John Wiley & Sons, Ltd., vol. 21(12), pages 1496-1498, December.
    6. Nádia Simões & Nuno Crespo & Sandrina B. Moreira & Celeste A. Varum, 2016. "Measurement and determinants of health poverty and richness: evidence from Portugal," Empirical Economics, Springer, vol. 50(4), pages 1331-1358, June.
    7. G Emmanuel Guindon & Paul Contoyannis, 2012. "A Response To Crémieux, Meilleur, Ouellette And Petit," Health Economics, John Wiley & Sons, Ltd., vol. 21(12), pages 1499-1501, December.
    8. Ruolz Ariste & Livio Di Matteo, 2017. "Value for money: an evaluation of health spending in Canada," International Journal of Health Economics and Management, Springer, vol. 17(3), pages 289-310, September.

  7. Jeremiah Hurley & G. Emmanuel Guindon & Vicki Rynard & Steve Morgan, 2008. "Publicly funded medical savings accounts: expenditure and distributional impacts in Ontario, Canada," Health Economics, John Wiley & Sons, Ltd., vol. 17(10), pages 1129-1151, October.

    Cited by:

    1. Wouters, Olivier J. & Cylus, Jonathan & Yang, Wei & Thomson, Sarah & McKee, Martin, 2016. "Medical savings accounts: assessing their impact on efficiency, equity, and financial protection in health care," LSE Research Online Documents on Economics 65448, London School of Economics and Political Science, LSE Library.
    2. Julie Shi & Yi Yao & Gordon Liu, 2018. "Modeling individual health care expenditures in China: Evidence to assist payment reform in public insurance," Health Economics, John Wiley & Sons, Ltd., vol. 27(12), pages 1945-1962, December.
    3. Jessica Leight & Nicholas Wilson, 2020. "Framing Flexible Spending Accounts: A Large‐Scale Field Experiment on Communicating the Return on Medical Savings Accounts," Health Economics, John Wiley & Sons, Ltd., vol. 29(2), pages 195-208, February.

More information

Research fields, statistics, top rankings, if available.

Statistics

Access and download statistics for all items

Co-authorship network on CollEc

NEP Fields

NEP is an announcement service for new working papers, with a weekly report in each of many fields. This author has had 2 papers announced in NEP. These are the fields, ordered by number of announcements, along with their dates. If the author is listed in the directory of specialists for this field, a link is also provided.
  1. NEP-HEA: Health Economics (2) 2008-12-01 2011-11-14
  2. NEP-DEV: Development (1) 2011-11-14
  3. NEP-IAS: Insurance Economics (1) 2008-12-01

Corrections

All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. For general information on how to correct material on RePEc, see these instructions.

To update listings or check citations waiting for approval, G Emmanuel Guindon should log into the RePEc Author Service.

To make corrections to the bibliographic information of a particular item, find the technical contact on the abstract page of that item. There, details are also given on how to add or correct references and citations.

To link different versions of the same work, where versions have a different title, use this form. Note that if the versions have a very similar title and are in the author's profile, the links will usually be created automatically.

Please note that most corrections can take a couple of weeks to filter through the various RePEc services.

IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.